{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T21:42:50Z","timestamp":1785620570416,"version":"3.56.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["P30EY025585"],"award-info":[{"award-number":["P30EY025585"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018313","name":"Cleveland Eye Bank Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012729","name":"Case Western Reserve University Clinical and Translational Science Collaborative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["\\u2014 UM1TR002548"],"award-info":[{"award-number":["\\u2014 UM1TR002548"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.oret.2026.02.019","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:54:41Z","timestamp":1772672081000},"page":"734-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors"],"prefix":"10.1016","volume":"10","author":[{"given":"Hejin","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"BS","given":"Sophie C.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-9515","authenticated-orcid":false,"given":"David C.","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2026.02.019_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/jpet.105.084145","article-title":"Role of tyrosine kinase inhibitors in cancer therapy","volume":"315","author":"Arora","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.oret.2026.02.019_bib2","doi-asserted-by":"crossref","DOI":"10.1007\/s11239-025-03151-w","article-title":"Tyrosine kinase inhibitors - balancing the haemostatic scales: a review of associated thrombosis and bleeding","author":"Butel-Simoes","year":"2025","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.oret.2026.02.019_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14728214.2023.2259790","article-title":"A review of emerging tyrosine kinase inhibitors as durable treatment of neovascular age-related macular degeneration","volume":"28","author":"Das","year":"2023","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.oret.2026.02.019_bib4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/ATVBAHA.120.314378","article-title":"Cancer therapy\u2013associated thrombosis","volume":"41","author":"Grover","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.oret.2026.02.019_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2017.05.008","article-title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","volume":"59","author":"Valent","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.oret.2026.02.019_bib7","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000641","article-title":"Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the American Heart Association","volume":"139","author":"Campia","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.oret.2026.02.019_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103440","article-title":"Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study","volume":"87","author":"Moik","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.oret.2026.02.019_bib9","article-title":"Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review","volume":"11","author":"Luo","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.oret.2026.02.019_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/ICB.0b013e3182160965","article-title":"Bilateral central retinal vein occlusion in a patient with disseminated metastatic renal cell carcinoma treated with sorafenib","volume":"6","author":"Szczepanik","year":"2012","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2026.02.019_bib11","doi-asserted-by":"crossref","first-page":"35181","DOI":"10.18632\/oncotarget.9285","article-title":"Metastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenib","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.oret.2026.02.019_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11912-016-0536-7","article-title":"An unusual case of central retinal vein occlusion and review of the toxicity profile of regorafenib in GIST patients","volume":"18","author":"Schvartsman","year":"2016","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.oret.2026.02.019_bib13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/ICB.0000000000000771","article-title":"Reversible retinal toxicity in a patient taking axitinib","volume":"15","author":"Jenkins","year":"2021","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2026.02.019_bib14","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/09273948.2022.2042318","article-title":"Bilateral central retinal vein occlusion associated with axitinib therapy: a case report","volume":"31","author":"Pyare","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2026.02.019_bib15","article-title":"Multimodal imaging of retinal changes in a patient taking axitinib","volume":"21","author":"Comcal\u0131","year":"2025","journal-title":"Curr Med Imaging"},{"key":"10.1016\/j.oret.2026.02.019_bib16","article-title":"Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition","volume":"27","author":"Foulsham","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.oret.2026.02.019_bib17","article-title":"Central retinal vein occlusion with cerebral infarction secondary to anlotinib treatment: a case report and literature review","volume":"14","author":"Chen","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.oret.2026.02.019_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000496197","article-title":"Impaired retinal circulation during axitinib treatment for metastatic renal cell carcinoma","volume":"10","author":"Kimura","year":"2019","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.oret.2026.02.019_bib19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00417-019-04337-8","article-title":"Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics","volume":"257","author":"Kunkler","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2026.02.019_bib20","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","article-title":"Clinical practice. Retinal-vein occlusion","volume":"363","author":"Wong","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2026.02.019_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.oret.2026.02.019_bib22","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.oret.2026.02.019_bib23","series-title":"RStudio: Integrated Development Environment for R","year":"2025"},{"key":"10.1016\/j.oret.2026.02.019_bib24","doi-asserted-by":"crossref","first-page":"C1375","DOI":"10.1152\/ajpcell.2001.280.6.C1375","article-title":"Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor","volume":"280","author":"Zachary","year":"2001","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.oret.2026.02.019_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0002-9394(98)00226-8","article-title":"Thrombin\u2013antithrombin III complex in acute retinal vein occlusion","volume":"126","author":"Iijima","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.02.019_bib26","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/ijc.27979","article-title":"Risk of venous thromboembolic events associated with VEGFR-TKIs: a systematic review and meta-analysis","volume":"132","author":"Qi","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.oret.2026.02.019_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00280-017-3386-6","article-title":"Risk of venous and arterial thromboembolic events associated with VEGFR-TKIs: a meta-analysis","volume":"80","author":"Liu","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.oret.2026.02.019_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.preteyeres.2008.02.002","article-title":"Regulation of retinal blood flow in health and disease","volume":"27","author":"Pournaras","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2026.02.019_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0026-2862(02)00016-X","article-title":"Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells","volume":"65","author":"Grammas","year":"2003","journal-title":"Microvasc Res"},{"key":"10.1016\/j.oret.2026.02.019_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.survophthal.2021.05.007","article-title":"Retinal toxicities of systemic anticancer drugs","volume":"67","author":"Arora","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2026.02.019_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2024.104756","article-title":"Repeated treatment with VEGF receptor inhibitors induces phenotypic changes in endothelial cells and pericytes in the rat retina","volume":"157","author":"Nakano","year":"2025","journal-title":"Microvasc Res"},{"key":"10.1016\/j.oret.2026.02.019_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/IAE.0000000000000242","article-title":"Retinal toxicities of cancer therapy drugs: biologics, small molecule inhibitors, and chemotherapies","volume":"34","author":"Liu","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.oret.2026.02.019_bib33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000501155","article-title":"MEK inhibitor\u2013associated central retinal vein occlusion associated with hyperhomocysteinemia and MTHFR variants","volume":"6","author":"Francis","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.oret.2026.02.019_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.oret.2026.02.019_bib35","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.oret.2026.02.019_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ajo.2025.06.010","article-title":"Treatment of retinal\/choroidal vascular diseases by sustained delivery of vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"277","author":"Dhoot","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2026.02.019_bib37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/MLR.0000000000001418","article-title":"Utilization of social determinants of health ICD-10 Z-codes among hospitalized patients in the United States, 2016\u20132017","volume":"58","author":"Truong","year":"2020","journal-title":"Med Care"},{"key":"10.1016\/j.oret.2026.02.019_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jamia\/ocac020","article-title":"Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility","volume":"29","author":"Kukhareva","year":"2022","journal-title":"J Am Med Inform Assoc"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026000953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653026000953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:27:45Z","timestamp":1782977265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653026000953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2468653026000953"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2026.02.019","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks of Retinal Vascular Occlusions with the Systemic Use of Tyrosine Kinase Inhibitors","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2026.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}